Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from the Benelux countries Belgium, Luxembourg and The Netherlands or involving organisations from these countries.

Total search results: 1684 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Gotham Therapeutics–SEVERAL: investment, 201810 financing round Series A $54m co-led by Versant Ventures + Forbion + SR One 2018-10-10
Gotham Therapeutics–Versant Ventures: investment, 201810 financing round Series A totalling $54m incl founding + co-lead investor Versant Ventures 2018-10-10
Argenx–Flanders (govt): grant, 201810 VLAIO grant €2.6m to explore new applications of ABDEG technology 2018-10-09
DSM–Lipotype: mass spectrometry services, 201810 collab supply of shotgun skin lipidomics services by Lipotype to Royal DSM 2018-10-08
Lipoid–Lipotype: mass spectrometry services, 201810 collab supply of shotgun skin lipidomics services by Lipotype to Lipoid GmbH 2018-10-08
Celyad–Horizon Discovery: shRNA technology, 201810– license excl to develop allogeneic CAR-T cell therapies 2018-10-04
Curetis–Yorkville Group: credit, 201810– up to €20m convertible notes with attached warrants to YA II PN Ltd 2018-10-02
CytoSen Therapeutics–JSR Corp: biologics contract manufacturing, 201810– supply of TK cell therapy products by KBI Biopharma 2018-10-02
Evonetix–Magic Micro: DNA synthesis technology, 201810– collab developm of MEMS for DNA synthesis with LioniX Intl 2018-10-01
Forbion–SEVERAL: investment, 201810 final close €360m of Forbion IV fund 2018-10-01
JSTI Group–Eurofins: investment, 201810– acquisition $175m cash+debt free of TestAmerica by Eurofins from JSTI Group (CN) 2018-10-01
KangStem Biotech–Orgenesis: cell therapy contract manufacturing, 201810– supply production of Furestem-AD in Europe by MaSTherCell 2018-10-01
Sanofi–Advent International: investment, 201804–201810 acquisition €1.9b (enterprise value) of Sanofi’s European generics business Zentiva by Advent 2018-10-01
Pfizer–Qiagen: companion diagnostics, 201809 collab existent CDx for precision medicines in onocology 2018-09-28
Tusk Therapeutics–Roche: investment, 201809 acquisition for €70m cash + €585m milestones with some assets spun out into Black Belt Therapeutics 2018-09-28
Minoryx–SEVERAL: investment, 201809 financing round Series B €21.3m led by Fund+ with SFPI + SRIW + Sambrinvest + all Series A investors 2018-09-26
Horama–V-Bio Ventures: investment, 201809 Series B investment €3.5m by V-Bio bringing total Series B round to €22.5m 2018-09-18
Argenx–SEVERAL: investment, 201809 public offering $300.6m with 3.475m ADSs at $86.5/ADS 2018-09-17
Luciole Medical–SEVERAL: investment, 201809 financing round Series A CHF5.3m (€4.7m) led by SVC Ltd (CreditSuisse) 2018-09-17
Galapagos–SEVERAL: investment, 201809 US public offering $300m w 2.575m new ordinary shares as ADSs at $116.5/ADS 2018-09-12
Clinical Research Laboratories (US)–Eurofins: investment, 201809 acquisition of CRL by Eurofins 2018-09-04
Miracor–SEVERAL: investment, 201809 financing round Series D totalling €30m final closing led by Ming Capital (CN) 2018-09-04
NTrans Technologies–EU (govt): grant, 201809– Horizon 2020 SME Instrument Grant €1.5m 2018-09-04
Wondfo Biotech–Biocartis: molecular diagnostics, 201809– collab 50/50 joint venture for commercialisation of Idylla platform in mainland China 2018-09-03
Kandy Therapeutics–Advent Venture Partners: investment, 201808 financing round Series C totalling £25m incl existing investor Advent Life Sciences 2018-08-29
Kandy Therapeutics–Forbion: investment, 201808 financing round Series C totalling £25m incl existing investor Forbion Capital Partners 2018-08-29
Kandy Therapeutics–Fountain Healthcare Partners: investment, 201808 financing round Series C totalling £25m incl existing investor Fountain HCP 2018-08-29
Kandy Therapeutics–Longitude Capital: investment, 201808 financing round Series C totalling £25m incl new investor Longitude Capital 2018-08-29
Kandy Therapeutics–OrbiMed: investment, 201808 financing round Series C totalling £25m incl existing investor OrbiMed 2018-08-29
Kandy Therapeutics–SEVERAL: investment, 201808 financing round Series C £25m from Longitude Capital + Advent LS + Fountain HCP + Forbion + OrbiMed 2018-08-29
c-LEcta–Capricorn Venture Partners: investment, 201808 financing round incl new + lead investor Capricorn investing via CSCF NV + Quest for Growth 2018-08-23
c-LEcta–SEVERAL: investment, 201808 financing round €na with new investors Capricorn Venture Partners + bm|t 2018-08-23
c-LEcta–Thuringia (govt): investment, 201808 financing round incl new + co-investor bm|t via MFT Mittelstands-Fonds Thüringen 2018-08-23
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures 2018-08-10
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP 2018-08-10
Artios Pharma–SV Health Investors: investment, 201808 financing round Series B totalling $84m incl existing + co-investor SV 2018-08-10
Bavarian Nordic–Paddock Circle Advisors: public relations, 201808 service existent for US by Paddock Circle Advisors 2018-08-09
Kiadis–Kreos Capital: credit, 201808– debt financing up to €20m in 2 tranches 9% annual interest + end of loan 5% of drawn amount + 41k warrants 2018-08-01
Laboratorios Ecosur–Eurofins: investment, 201807 acquisition of Ecosur by Eurofins 2018-07-27
Azafaros–SEVERAL: investment, 201807 seed financing round with BGV as founding investor 2018-07-23
SHS–SEVERAL: investment, 201807 first closing €90m of SHS V fund with target size of €150m 2018-07-20
Gilead–Gadeta: cancer immunotherapy, 201807– collab r+d gd-TCRs with Kite incl r+d funding + up front + milestones + excl option to acquire Gadeta 2018-07-19
Novartis–MorphoSys: therapeutic antibody, 201807– license excl ww to MOR106 from MOR+GLPG €95m upfront + €850m milestones + royalties + funding 2018-07-19
Beiersdorf–S-Biomedic: skin microbiomics, 201807– collaboration 2018-07-18
DCPrime–Glycotope: cancer immunotherapy, 201807– license + collab agreement research new approaches to solid tumours 2018-07-18
S-Biomedic–Beiersdorf: investment, 201807 financing round Series A 1st closing totalling €2m incl lead investor Beiersdorf AG 2018-07-18
S-Biomedic–JnJ: investment, 201807 financing round Series A 1st closing totalling €2m incl co-investor JnJ Innovation JJDC 2018-07-18
S-Biomedic–SEVERAL: investment, 201807 financing round Series A 1st closing €2m led by Beiersdorf + incl investiere.ch + JnJ Innovation JJDC 2018-07-18
S-Biomedic–Verve Capital Partners: investment, 201807 financing round Series A 1st closing totalling €2m incl co-investor investiere.ch 2018-07-18
Univercells–Global Health Investment Fund: investment, 201807 financing round Series B totalling €16m incl lead investor GHIF 2018-07-16
Univercells–SEVERAL: investment, 201807 financing round Series B €16m led by Global Health Investment Fund 2018-07-16
Forbion–SEVERAL: investment, 201807 first close €270m of Forbion IV fund 2018-07-11
IMMUNOMONITOR project–Biomax: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–Enpicom: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–EU (govt): grant, 201807– Eurostars grant €2m to develop clin validation for treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–OSE Immunotherapeutics: pharmacogenomics, 201807– collab project partner develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Ultimovacs: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Univ Hamburg: pharmacogenomics, 201807– collab partner Eurostars in project develop validation treatm response cancer vaccines 2018-07-05
Netherlands (govt)–iVention: LIMS, 201807– supply iLES platform to RIVM for Neonatal Bloodspot Prick Screening 2018-07-05
Laboratoire de Bromatologie de l’Ouest–Eurofins: investment, 201807 acquisition of LBO by Eurofins 2018-07-03
Lactotronic–Bruker: investment, 201807 acquisition €na of Lactotronic BV by Bruker 2018-07-03
LioniX–Magic Micro: investment, 201807 acquisition of 75% majority share in LioniX International BV by Magic Micro Co Ltd 2018-07-03
VarmX–BioGeneration Ventures: investment, 201807 financing round Series A totalling €7.5m incl lead + existing investor BGV 2018-07-02
VarmX–InnovationQuarter (NL): investment, 201807 financing round Series A totalling €7.5m incl existing co-investor InnovationQuarter Capital 2018-07-02
VarmX–LifeSpring: public relations, 201807 service existent by LifeSpring Communications 2018-07-02
VarmX–Netherlands (govt): credit, 201807– Innovation Credit €5m from RVO.nl 2018-07-02
VarmX–SEVERAL: investment, 201807 financing round Series A €7.5m with lead + existing investor BGV plus existing investor InnovationQuarter 2018-07-02
MDxHealth–SEVERAL: investment, 2018H1 capital increase €36m 2018-06-30
Aptamer Group–Meneldor: investment, 201806 financing round Series A totalling $2.2m incl investor Meneldor 2018-06-29
Aptamer Group–SEVERAL: investment, 201806 financing round Series A $2.2m from international inevstors incl Meneldor 2018-06-29
Exosome Diagnostics–Bio-Techne: investment, 201806– acquisition $250m cash + $325m milestones of Exosome Dx by Bio-Techne ANNOUNCED 2018-06-25
iTeos Therapeutics–6 Dimensions Capital: investment, 201806 financing round Series B totalling €64m incl new + co-investor 6 Dimensions Capital 2018-06-20
iTeos Therapeutics–Belgium (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SFPI 2018-06-20
iTeos Therapeutics–Curative Ventures: investment, 201806 financing round Series B totalling €64m incl new + co-investor Curative Ventures 2018-06-20
iTeos Therapeutics–Fund+: investment, 201806 financing round Series B totalling €64m incl existing + co-investor Fund+ 2018-06-20
iTeos Therapeutics–HBM: investment, 201806 financing round Series B totalling €64m incl new + co-investor HBM Partners 2018-06-20
iTeos Therapeutics–MPM Capital: investment, 201806 financing round Series B totalling €64m incl new + lead investor MPM Capital 2018-06-20
iTeos Therapeutics–SEVERAL: investment, 201806 financing round Series B €64m led by MPM Capital 2018-06-20
iTeos Therapeutics–Univ Leuven: investment, 201806 financing round Series B totalling €64m incl existing + co-investor VIVES II 2018-06-20
iTeos Therapeutics–Wallonia (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SRIW 2018-06-20
Noxxon–SEVERAL: credit, 201806– convertible bond €380k from existing investors 2018-06-15
Remote Diagnostic Technologies–Philips: investment, 201806 acquisition €na of RDT by Philips 2018-06-13
StrideBio–Alexandria Real Estate: investment, 201806 financing round Series A totalling $15.7m incl co-investor Alexandria Venture Investments 2018-06-13
StrideBio–Hatteras Venture Partners: investment, 201806 financing round Series A totalling $15.7m incl lead investor Hatteras Venture Partners 2018-06-13
StrideBio–SEVERAL: investment, 201806 financing round Series A $15.7m led by Hatteras Venture Partners 2018-06-13
StrideBio–Takeda: investment, 201806 financing round Series A totalling $15.7m incl co-investor Takeda Ventures Inc 2018-06-13
StrideBio–UCB: investment, 201806 financing round Series A totalling $15.7m incl co-investor UCB Ventures 2018-06-13
TxCell–Lonza: cell therapy contract manufacturing, 201805– supply of TX200 for clinical studies by Lonza production site in Geleen (NL) 2018-05-31
AbCellera–Harbour BioMed: drug discovery services, 201805– collab integration single-cell Ab discovery services w H2L2 transgenic mouse platform 2018-05-30
Treeway–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-29
ThromboGenics–Bicycle Therapeutics: small-molecule drugs, 201805– collab expansion r+d of bicycle peptides for eye diseases 2018-05-25
Lava Therapeutics–Gilde Investment: investment, 201805 financing round totalling €16m incl new + co-lead investor Gilde Healthcare 2018-05-23
Lava Therapeutics–Merck (US): investment, 201805 financing round totalling €16m incl new + co-investor MRL Ventures Fund 2018-05-23
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

» top